[Treatment of heart failure with beta-blockaders].
Since 1975 several studies have indicated that treatment with beta-adrenergic blocking drugs has a positive effect on prognosis in patients with left ventricular dysfunction. After myocardial infarction, treatment with timolol and propranolol improves prognosis in patients with symptoms of cardiomegaly and heart failure. In patients with idiopathic dilated cardiomyopathy, treatment with metoprolol improves the left ventricular ejection fraction and symptoms of heart failure, and may have a positive effect on prognosis. Recent studies of patients with chronic congestive heart failure also indicate that carvedilol has a positive effect on mortality and morbidity. The authors review some relevant studies, to stimulate the use of beta-adrenergic blocking drugs to treat certain types of heart failure.
Gundersen
T
T
Medisinsk avdeling, Aust-Agder Sentralsjukehus, Arendal.
Dickstein
K
K
Hole
T
T
Kjekshus
J
J
Myhre
E S
ES
Rønnevik
P
P
Smith
P
P
Westheim
A
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans
D000319:Adrenergic beta-Antagonists
Betablokkerbehandling av hjertesviktpasienter.